~~<i id='E40DCD0903'><strike id='E40DCD0903'><tt id='E40DCD0903'><pre id='E40DCD0903'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：entertainment 2025-09-29 04:02:52 Page View：5

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moderna says combo Covid
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

ARIANADREHSLER/AFPviaGettyImagesSANDIEGO— U.S.legislationthatseekstorestrictAmericanbiotechsfromwork

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

CraigF.Walker/TheBostonGlobeMaryBrownwassippingcoffeeathomeinOntario,Calif.,Sundaymorningwhenafriend

WSS

leisure time

leisure time

knowledge

Wikipedia

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit